Page last updated: 2024-08-26

terameprocol and betadex

terameprocol has been researched along with betadex in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blomberg, JA; Goodman, AB; Heller, J; Lopez, RA; Rhodes, M1

Other Studies

1 other study(ies) available for terameprocol and betadex

ArticleYear
The anticancer activity of the transcription inhibitor terameprocol (meso-tetra-O-methyl nordihydroguaiaretic acid) formulated for systemic administration.
    Anti-cancer drugs, 2007, Volume: 18, Issue:8

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Dimethyl Sulfoxide; Excipients; Female; Humans; Infusions, Intravenous; Injections, Intraperitoneal; Masoprocol; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Polyethylene Glycols; Survival Analysis

2007